Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company

Refine Search
Americas
AbbVie has announced yet another settlement relating to litigation over Humira, a drug used to treat multiple types of arthritis as well as psoriasis.   12 October 2018
Biotechnology
The patenting of personalised healthcare inventions has proved problematic in a 
number of jurisdictions, but various aspects of these inventions are patentable in Europe, as Laurence Gainey of HGF explains.   12 October 2018
Americas
Eli Lilly has filed a complaint against France-based biotechnology company Adocia over patents relating to fast-acting insulin.   11 October 2018
Biotechnology
Cancer biosimilars are slow to enter European drugs markets even after the branded products have gone off-patent, according to the Association of European Cancer Leagues.   11 October 2018
Americas
The US Food and Drug Administration has released guidance intended to advance the development of generic versions of complex medical drugs.   11 October 2018
Americas
Biologics patent owners should consider the US International Trade Commission as a supplement (or alternative) to district court litigation, say Filko Prugo, Charlotte Jacobsen, Matt Rizzolo and Henry Huang of Ropes & Gray.   10 October 2018
Americas
The US Court of Appeals for the Federal Circuit yesterday upheld a district court ruling that invalidated a patent owned by Roche Molecular Systems, a division of Roche that makes equipment and reagents.   10 October 2018
Americas
Tom Duley has joined Sidley Austin after spending nearly five years at King & Spalding.   10 October 2018
Americas
A proposed amendment in Mexican law needs to be implemented urgently in order to adapt legislation to include provisions in accordance with the UPOV Convention, as Luz Flores of Uhthoff, Gómez Vega & Uhthoff reports.   10 October 2018
Americas
A former Johnson & Johnson IP counsel and a retired judge are among the speakers at Life Sciences IP Due Diligence, on November 29 and 30 in Boston, as LSIPR finds out.   10 October 2018